Article Text

Download PDFPDF
The TNT study, women and cancer
  1. M R Goldstein1,
  2. L Mascitelli2,
  3. F Pezzetta3
  1. 1
    Fountain Medical Court, Bonita Springs, Florida, USA
  2. 2
    Medical Service, Comando Brigata alpina Julia, Udine, Italy
  3. 3
    Cardiology Service, Ospedale di Tolmezzo, Tolmezzo, Italy
  1. Dr M R Goldstein, Fountain Medical Court, 9410 Fountain Medical Court, Suite A-200, Bonita Springs, FL 34135, USA; markrgoldstein{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the editor: We read the interesting secondary analysis of the 4.9-year Treating to New Targets (TNT) study1 reporting the effects of aggressive low-density lipoprotein cholesterol lowering in women (median age 63.5 years) with stable coronary heart disease. In view of the reported data, we have serious concerns about the large excess in cancer mortality seen among the women randomised to high-dose atorvastatin (80 mg daily) therapy compared with …

View Full Text


  • Competing interests: None.

Linked Articles

  • Featured correspondence
    N K Wenger V Bittner D M Herrington S J Lewis F K Welty